Keesha Powell-Roach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keesha Powell-Roach has a total of 211 co-authors. Here are the top co-authors by number of shared publications:
- Diana J. Wilkie
Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL
10 shared publications Yingwei Yao
Department of Biobehavioral Nursing Science, University of Florida College of Nursing, Gainesville, Florida
9 shared publications- Staja. Q. Booker
University of Florida
8 shared publications - Judith M. Schlaeger
Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, United States
5 shared publications Marie L. Suarez
Department of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA
5 shared publicationsRobert E. Molokie
College of Medicine & College of Pharmacy, University of Illinois, Chicago, IL; Hematology/Medical Oncology, Jesse Brown VA Medical Center, Chicago, IL
5 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (11) , e72462
Cost‐Related Medication Underuse and Coping Behaviors in Breast Cancer Survivors Taking Cardiovascular Risk Reduction Medication Enrolled in the National Institutes of Health All of us Research Program
Background: Breast cancer survivors are at increased risk of cardiovascular disease throughout survivorship. Recent studies documented suboptimal adherence to cardiovascular risk reduction medications, but studies identifying contributors to this behavior are lacking. The association between sociodemographic characteristics, social drivers of health factors, and cost‐related medication behaviors in survivors who were taking antihyperlipidemics or antihypertensives was evaluated. Methods: These cross‐sectional analyses utilized data from the National Institutes of Health All of Us Research Program from May 31, 2017 to October 1, 2023. Cohort eligibility included identifying as Black/African American or White, being at least 18 years old, and having a diagnosis of breast cancer. The outcome, cost‐related medication underuse and coping behaviors, was assessed using a seven‐item scale. Bivariable and multivariable logistic regression models were used to evaluate the associations of covariates and the outcome for each of the cardiovascular risk medication classes. Results: Compared to Black survivors, White survivors had higher odds of asking for lower‐cost medications among antihyperlipidemics users (pooled adjusted OR = 1.69; 95% CI: 1.18–2.40; FDR‐adjusted p = 0.012) and antihypertensives users (pooled adjusted OR = 2.03; 95% CI: 1.50–2.76; FDR‐adjusted p = 0.004). Survivors who reported greater social support were less likely to delay filling their prescription to save money when compared to survivors who reported lower social support. Conclusions: Some survivors are more likely to engage in cost‐related coping and underuse behaviors than others. Clinicians, including primary care providers, should include discussions and resources about non‐cancer therapy adherence‐related financial challenges with their patients who are cancer survivors.
- 5 November 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (11) , e72462
Open AccessCost‐Related Medication Underuse and Coping Behaviors in Breast Cancer Survivors Taking Cardiovascular Risk Reduction Medication Enrolled in the National Institutes of Health All of us Research Program
Background: Breast cancer survivors are at increased risk of cardiovascular disease throughout survivorship. Recent studies documented suboptimal adherence to cardiovascular risk reduction medications, but studies identifying contributors to this behavior are lacking. The association between sociodemographic characteristics, social drivers of health factors, and cost‐related medication behaviors in survivors who were taking antihyperlipidemics or antihypertensives was evaluated. Methods: These cross‐sectional analyses utilized data from the National Institutes of Health All of Us Research Program from May 31, 2017 to October 1, 2023. Cohort eligibility included identifying as Black/African American or White, being at least 18 years old, and having a diagnosis of breast cancer. The outcome, cost‐related medication underuse and coping behaviors, was assessed using a seven‐item scale. Bivariable and multivariable logistic regression models were used to evaluate the associations of covariates and the outcome for each of the cardiovascular risk medication classes. Results: Compared to Black survivors, White survivors had higher odds of asking for lower‐cost medications among antihyperlipidemics users (pooled adjusted OR = 1.69; 95% CI: 1.18–2.40; FDR‐adjusted p = 0.012) and antihypertensives users (pooled adjusted OR = 2.03; 95% CI: 1.50–2.76; FDR‐adjusted p = 0.004). Survivors who reported greater social support were less likely to delay filling their prescription to save money when compared to survivors who reported lower social support. Conclusions: Some survivors are more likely to engage in cost‐related coping and underuse behaviors than others. Clinicians, including primary care providers, should include discussions and resources about non‐cancer therapy adherence‐related financial challenges with their patients who are cancer survivors.
- Open Access
- 22 September 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1907108
Chronic pain in the aging adult with sickle cell disease
Improved survival in sickle cell disease (SCD) has led to a growing population of older adults who experience a high burden of chronic pain. With aging, pain often shifts from episodic vaso-occlusive crises to persistent, multifactorial syndromes driven by cumulative tissue injury, central sensitization, and progressive organ damage. This evolution presents significant clinical challenges, particularly in the context of comorbidities, polypharmacy, and age-related physiological changes. This narrative review examines the epidemiology, pathophysiology, and management of chronic pain in aging adults with SCD. Key contributors to pain include musculoskeletal degeneration, neuropathic mechanisms, and chronic inflammation, compounded by renal, hepatic, and cardiovascular dysfunction. Pharmacological management requires careful consideration of analgesic safety, particularly with opioids, nonsteroidal anti-inflammatory drugs, and adjuvant agents. Nonpharmacological approaches, including rehabilitative and behavioral strategies, are essential components of care. Psychosocial factors and health disparities further influence pain experiences and treatment outcomes. A multidisciplinary, individualized approach integrating geriatric and SCD-specific principles is critical to improving quality of life in this vulnerable population.
- 22 September 2026
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 7, 1907108
Open AccessChronic pain in the aging adult with sickle cell disease
Improved survival in sickle cell disease (SCD) has led to a growing population of older adults who experience a high burden of chronic pain. With aging, pain often shifts from episodic vaso-occlusive crises to persistent, multifactorial syndromes driven by cumulative tissue injury, central sensitization, and progressive organ damage. This evolution presents significant clinical challenges, particularly in the context of comorbidities, polypharmacy, and age-related physiological changes. This narrative review examines the epidemiology, pathophysiology, and management of chronic pain in aging adults with SCD. Key contributors to pain include musculoskeletal degeneration, neuropathic mechanisms, and chronic inflammation, compounded by renal, hepatic, and cardiovascular dysfunction. Pharmacological management requires careful consideration of analgesic safety, particularly with opioids, nonsteroidal anti-inflammatory drugs, and adjuvant agents. Nonpharmacological approaches, including rehabilitative and behavioral strategies, are essential components of care. Psychosocial factors and health disparities further influence pain experiences and treatment outcomes. A multidisciplinary, individualized approach integrating geriatric and SCD-specific principles is critical to improving quality of life in this vulnerable population.
- Open Access
- 26 August 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (5) , 517
Beyond Pain: A Pilot Study of Neurodegenerative and Mitochondrial Pathway Alterations in Sickle Cell Disease Using Platelet Proteomics
Background: Sickle cell disease (SCD) is a systemic disorder marked by chronic pain and neurocognitive deficits, yet the molecular drivers of these neurocognitive features remain poorly defined. Platelets, central to inflammation and vascular homeostasis, may reflect broad pathophysiologic processes in SCD. Methods: We performed high-resolution mass spectrometry on ultra-purified platelets from 16 adults with SCD and moderate to severe pain (self-reported ≥ 3/10 in the past year), identifying 4196 proteins, of which 1046 were significant (FDR < 0.05). Unsupervised clustering was used to stratify individuals into high- and low-pain phenotypes. Results: Contrary to expectations, canonical pain pathways were not enriched. Instead, significant alterations were observed in neurodegeneration, mitochondrial metabolism, ATP regulation, mitophagy, and tRNA aminoacylation pathways between high- and low-pain phenotypes. High-pain individuals exhibited elevated levels of proteins involved in proteostasis and neurodegenerative disease processes, whereas low-pain individuals showed increased expression of proteins linked to mitochondrial integrity, neuroprotection, and reduced oxidative stress. Protein-protein interaction networks revealed tightly connected clusters within neurodegenerative and central nervous system-related pathways. Disease association analysis ranked neurodegenerative and mitochondrial pathways above traditional hematologic and nociceptive mechanisms. Conclusions: These findings suggest that platelet proteomics may serve as a peripheral window into PNS or CNS vulnerability and cognitive risk in SCD. The enrichment of tRNA aminoacylation and mitochondrial regulation pathways underscores the metabolic complexity of SCD and highlights novel targets for biomarker development and therapeutic intervention.
- 26 August 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (5) , 517
Open AccessBeyond Pain: A Pilot Study of Neurodegenerative and Mitochondrial Pathway Alterations in Sickle Cell Disease Using Platelet Proteomics
Background: Sickle cell disease (SCD) is a systemic disorder marked by chronic pain and neurocognitive deficits, yet the molecular drivers of these neurocognitive features remain poorly defined. Platelets, central to inflammation and vascular homeostasis, may reflect broad pathophysiologic processes in SCD. Methods: We performed high-resolution mass spectrometry on ultra-purified platelets from 16 adults with SCD and moderate to severe pain (self-reported ≥ 3/10 in the past year), identifying 4196 proteins, of which 1046 were significant (FDR < 0.05). Unsupervised clustering was used to stratify individuals into high- and low-pain phenotypes. Results: Contrary to expectations, canonical pain pathways were not enriched. Instead, significant alterations were observed in neurodegeneration, mitochondrial metabolism, ATP regulation, mitophagy, and tRNA aminoacylation pathways between high- and low-pain phenotypes. High-pain individuals exhibited elevated levels of proteins involved in proteostasis and neurodegenerative disease processes, whereas low-pain individuals showed increased expression of proteins linked to mitochondrial integrity, neuroprotection, and reduced oxidative stress. Protein-protein interaction networks revealed tightly connected clusters within neurodegenerative and central nervous system-related pathways. Disease association analysis ranked neurodegenerative and mitochondrial pathways above traditional hematologic and nociceptive mechanisms. Conclusions: These findings suggest that platelet proteomics may serve as a peripheral window into PNS or CNS vulnerability and cognitive risk in SCD. The enrichment of tRNA aminoacylation and mitochondrial regulation pathways underscores the metabolic complexity of SCD and highlights novel targets for biomarker development and therapeutic intervention.
- Open Access
- 13 March 2026
- Published by Elsevier in The Journal of Pain
- Vol. 43, 106261
Sociodemographic patterns and associations between perceived healthcare discrimination and pain severity in the All of Us Research Program
- 13 March 2026
- Published by Elsevier in The Journal of Pain
- Vol. 43, 106261
Open AccessSociodemographic patterns and associations between perceived healthcare discrimination and pain severity in the All of Us Research Program
- 24 February 2026
- Published by Wolters Kluwer Health in Journal of the American Association of Nurse Practitioners
- Vol. 38 (10) , 769-776
Demographic factors and rural residence history associated with smoking history
Background: Understanding personal and geographic factors associated with smoking is important to design and implement interventions focused on reducing cancer health disparities. Scant research has been published recently regarding factors associated with smoking history associations within rural communities. Purpose: To examine demographic factors and rural residence history for associations with smoking history. Methodology: In a cross-sectional study of cancer-related behaviors, 1,786 adults (mean age 47.9 ± 17.5 years; 53% female, 84% White) completed an online survey in 2020. We examined factors associated with smoking history (having smoked at least 100 cigarettes) using independent t-tests, chi-square tests, and logistic regression. Results: Of the participants, 36% had a rural residence history and 49% had a smoking history. A larger proportion of men than women (61% vs. 37%; p < .001), White than Black participants (50% vs. 39%; p = .001), and rural than nonrural residents (53% vs. 46%; p = .005) had a smoking history. Logistic regression analysis revealed that the young age group (18–30) was less likely ( p = .002), whereas the middle age group (31–50) was more likely ( p < .001) to have a smoking history than those older than 50 years. Rural residence was associated with a smoking history among women ( p < .001), but not among men ( p = .70) in this sample. Conclusions: Tobacco control efforts are needed to focus on middle-aged men in general and women with rural residence history. Implications: Nurse practitioners are uniquely positioned to directly contribute to future research with self-identified rural populations that could help inform future public health policy.
- 24 February 2026
- Published by Wolters Kluwer Health in Journal of the American Association of Nurse Practitioners
- Vol. 38 (10) , 769-776
Demographic factors and rural residence history associated with smoking history
Background: Understanding personal and geographic factors associated with smoking is important to design and implement interventions focused on reducing cancer health disparities. Scant research has been published recently regarding factors associated with smoking history associations within rural communities. Purpose: To examine demographic factors and rural residence history for associations with smoking history. Methodology: In a cross-sectional study of cancer-related behaviors, 1,786 adults (mean age 47.9 ± 17.5 years; 53% female, 84% White) completed an online survey in 2020. We examined factors associated with smoking history (having smoked at least 100 cigarettes) using independent t-tests, chi-square tests, and logistic regression. Results: Of the participants, 36% had a rural residence history and 49% had a smoking history. A larger proportion of men than women (61% vs. 37%; p < .001), White than Black participants (50% vs. 39%; p = .001), and rural than nonrural residents (53% vs. 46%; p = .005) had a smoking history. Logistic regression analysis revealed that the young age group (18–30) was less likely ( p = .002), whereas the middle age group (31–50) was more likely ( p < .001) to have a smoking history than those older than 50 years. Rural residence was associated with a smoking history among women ( p < .001), but not among men ( p = .70) in this sample. Conclusions: Tobacco control efforts are needed to focus on middle-aged men in general and women with rural residence history. Implications: Nurse practitioners are uniquely positioned to directly contribute to future research with self-identified rural populations that could help inform future public health policy.
- Open Access
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
Haloperidol or amitriptyline for chronic neuropathic pain in adults with SCD: a systematic review
Chronic pain affects more than half of adults with SCD, and a clinically meaningful subgroup—reported in 32%-70% of cohorts depending on the screening tool—exhibits a neuropathic component that is poorly responsive to opioids and other standard analgesics. The 2020 American Society of Hematology guideline conditionally suggests tricyclic antidepressants (eg, amitriptyline) for SCD-related chronic pain on the basis of indirect, very-low-certainty evidence extrapolated from fibromyalgia, and is silent on haloperidol despite preclinical and translational evidence implicating Ca2+/calmodulin-dependent protein kinase IIα (CaMKIIα) and sigma-1 receptor pathways in SCD pain and in the analgesic activity of butyrophenone and phenothiazine antipsychotics. CaMKIIα activation has been demonstrated in the dorsal root ganglia and in the spinal cord superficial dorsal horn of Berkeley sickle transgenic mice, and CaMKIIα inhibitors (the phenothiazine trifluoperazine and the butyrophenone haloperidol) attenuate evoked and spontaneous pain in preclinical models; trifluoperazine has further shown preliminary analgesic activity in a phase I study in adults with SCD. In this systematic review, we asked whether direct evidence supports the use of haloperidol or amitriptyline for chronic neuropathic pain in adults with SCD. PubMed, CINAHL, and Embase were searched from inception through May 7, 2026, supplemented by reference checking of 26 publications on related topics. No eligible studies were identified for either drug. Adjacent neuropathic pain evidence supports modest amitriptyline benefit (NNT ∼5; NNH ∼5) and a plausible but unproven CaMKIIα/σ1R-mediated rationale for haloperidol. Adequately powered, phenotypically enriched, safety-monitored SCD-specific RCTs of both agents are an urgent research priority.
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
Open AccessHaloperidol or amitriptyline for chronic neuropathic pain in adults with SCD: a systematic review
Chronic pain affects more than half of adults with SCD, and a clinically meaningful subgroup—reported in 32%-70% of cohorts depending on the screening tool—exhibits a neuropathic component that is poorly responsive to opioids and other standard analgesics. The 2020 American Society of Hematology guideline conditionally suggests tricyclic antidepressants (eg, amitriptyline) for SCD-related chronic pain on the basis of indirect, very-low-certainty evidence extrapolated from fibromyalgia, and is silent on haloperidol despite preclinical and translational evidence implicating Ca2+/calmodulin-dependent protein kinase IIα (CaMKIIα) and sigma-1 receptor pathways in SCD pain and in the analgesic activity of butyrophenone and phenothiazine antipsychotics. CaMKIIα activation has been demonstrated in the dorsal root ganglia and in the spinal cord superficial dorsal horn of Berkeley sickle transgenic mice, and CaMKIIα inhibitors (the phenothiazine trifluoperazine and the butyrophenone haloperidol) attenuate evoked and spontaneous pain in preclinical models; trifluoperazine has further shown preliminary analgesic activity in a phase I study in adults with SCD. In this systematic review, we asked whether direct evidence supports the use of haloperidol or amitriptyline for chronic neuropathic pain in adults with SCD. PubMed, CINAHL, and Embase were searched from inception through May 7, 2026, supplemented by reference checking of 26 publications on related topics. No eligible studies were identified for either drug. Adjacent neuropathic pain evidence supports modest amitriptyline benefit (NNT ∼5; NNH ∼5) and a plausible but unproven CaMKIIα/σ1R-mediated rationale for haloperidol. Adequately powered, phenotypically enriched, safety-monitored SCD-specific RCTs of both agents are an urgent research priority.
- Open Access
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
Nursing without borders: culturally tailoring a US SCD nursing excellence train-the-trainer bootcamp model for nurses in Nigeria and across Africa
Objectives: To address the lack of structured sickle cell disease (SCD) training and missed opportunities for early identification, intervention, and improved patient outcomes in resource limited settings, the U.S. based SCD Nursing Excellence Train-the-Trainer Bootcamp was adapted and delivered to nurses in Abuja, Nigeria. Methods: Adaptation of the U.S. based SCD Bootcamp curriculum and assessments was facilitated through an embedded mixed methods design. Nurses across Africa were competitively selected. All participants received accommodations and meals; Nigerian nurses were reimbursed for transportation costs. Eight SCD nurse experts, with local nurses’ input adapted the U.S. bootcamp curriculum and developed 20 items for pre- and post-test knowledge assessment. Self-efficacy was assessed using the Evidence-Based Nursing Practice Self-Efficacy Scale. The bootcamp included SCD related complications and associated nursing management. Wilcoxon ranked sum test and paired sample t test were used to establish change in knowledge and self-efficacy, respectively. Alpha level of 0.05 was used for all statistical tests. Results: The Nigerian bootcamp was successfully held from May 30 to June 1, 2025, with 35 nurses attending from six regions of Nigeria (30), Ghana (1), Sierra Leone (3), and Tanzania (1). The mean number of knowledge questions answered correctly at baseline was 15.8 and 18.1 post bootcamp; mean difference (95% CI) 2.26 (1.3, 3.2), P = .00004. Baseline self-efficacy was 78.4% and 87.6% post bootcamp [t(34) = −3.47, P = .00144]. Conclusion: The SCD Nursing Excellence Train-the-Trainer Bootcamp was effectively adapted to a low-resource setting through intentional collaboration and local engagement.
- 15 January 2026
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 3 (1)
Open AccessNursing without borders: culturally tailoring a US SCD nursing excellence train-the-trainer bootcamp model for nurses in Nigeria and across Africa
Objectives: To address the lack of structured sickle cell disease (SCD) training and missed opportunities for early identification, intervention, and improved patient outcomes in resource limited settings, the U.S. based SCD Nursing Excellence Train-the-Trainer Bootcamp was adapted and delivered to nurses in Abuja, Nigeria. Methods: Adaptation of the U.S. based SCD Bootcamp curriculum and assessments was facilitated through an embedded mixed methods design. Nurses across Africa were competitively selected. All participants received accommodations and meals; Nigerian nurses were reimbursed for transportation costs. Eight SCD nurse experts, with local nurses’ input adapted the U.S. bootcamp curriculum and developed 20 items for pre- and post-test knowledge assessment. Self-efficacy was assessed using the Evidence-Based Nursing Practice Self-Efficacy Scale. The bootcamp included SCD related complications and associated nursing management. Wilcoxon ranked sum test and paired sample t test were used to establish change in knowledge and self-efficacy, respectively. Alpha level of 0.05 was used for all statistical tests. Results: The Nigerian bootcamp was successfully held from May 30 to June 1, 2025, with 35 nurses attending from six regions of Nigeria (30), Ghana (1), Sierra Leone (3), and Tanzania (1). The mean number of knowledge questions answered correctly at baseline was 15.8 and 18.1 post bootcamp; mean difference (95% CI) 2.26 (1.3, 3.2), P = .00004. Baseline self-efficacy was 78.4% and 87.6% post bootcamp [t(34) = −3.47, P = .00144]. Conclusion: The SCD Nursing Excellence Train-the-Trainer Bootcamp was effectively adapted to a low-resource setting through intentional collaboration and local engagement.
- Open Access
- 1 October 2025
- Published by SAGE Publications in Health Informatics Journal
- Vol. 31 (4)
Methods to modernize a multimedia, web-based reproductive health education intervention for individuals with sickle cell disease or trait using virtual human narration and user-centered design
Objectives: For a population that lacks genetic inheritance knowledge about sickle cell disease/trait, a previously innovative web-based intervention showed significant and sustained knowledge improvement, but current users judged it as “dated.” We aimed to modernize the reproductive health intervention, revitalizing its presentation format and providing access to it via all operating systems and browsers. Methods: Young adults (N = 82, mean age 30.3 ± 5.8 years, 76% female, 94% Black, 74% never married) and our interdisciplinary team collaborated in an iterative, user-centered redesign process. We added virtual human narration and interactive interface enhancements to improve accessibility, engagement, and cross-platform compatibility. Functionality testing continued iteratively until all components operated as intended across devices and browsers. Results: After 9 months of redevelopment, the educational program functioned as intended on Windows, Android, and Apple computers and mobile devices. Of the 82 users, 100% enjoyed using it, and 95% indicated it was easy to use. Conclusion: Redevelopment required 6 months longer than expected due to the scope of the updates and integration of advanced features. Designed for an underserved population, the modernized intervention is now undergoing evaluation in a randomized controlled trial. Future directions include the integration of conversational AI and broader application in digital health education.
- 1 October 2025
- Published by SAGE Publications in Health Informatics Journal
- Vol. 31 (4)
Open AccessMethods to modernize a multimedia, web-based reproductive health education intervention for individuals with sickle cell disease or trait using virtual human narration and user-centered design
Objectives: For a population that lacks genetic inheritance knowledge about sickle cell disease/trait, a previously innovative web-based intervention showed significant and sustained knowledge improvement, but current users judged it as “dated.” We aimed to modernize the reproductive health intervention, revitalizing its presentation format and providing access to it via all operating systems and browsers. Methods: Young adults (N = 82, mean age 30.3 ± 5.8 years, 76% female, 94% Black, 74% never married) and our interdisciplinary team collaborated in an iterative, user-centered redesign process. We added virtual human narration and interactive interface enhancements to improve accessibility, engagement, and cross-platform compatibility. Functionality testing continued iteratively until all components operated as intended across devices and browsers. Results: After 9 months of redevelopment, the educational program functioned as intended on Windows, Android, and Apple computers and mobile devices. Of the 82 users, 100% enjoyed using it, and 95% indicated it was easy to use. Conclusion: Redevelopment required 6 months longer than expected due to the scope of the updates and integration of advanced features. Designed for an underserved population, the modernized intervention is now undergoing evaluation in a randomized controlled trial. Future directions include the integration of conversational AI and broader application in digital health education.
- 24 July 2025
- Published by Elsevier in Pain Management Nursing
- Vol. 27 (1) , e17-e25
Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review
- 24 July 2025
- Published by Elsevier in Pain Management Nursing
- Vol. 27 (1) , e17-e25
Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review
- Open Access
- 17 January 2025
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 2 (1)
SCD Nursing Education: A Scoping Review
SCD is a rare, inherited blood disorder that disproportionately affects Black patients. Individuals living with SCD experience significant pain crises and complications due to the sickling of red blood cells. These pain crises cause complications that affect every body system and are extremely dangerous, requiring immediate recognition and intervention to prevent severe complications and death. Nurses are the primary care providers for these individuals across the care continuum, but they often lack the knowledge and skills to do so effectively. There is a dearth of nursing education about SCD in undergraduate to post-graduate nursing professional education. This review highlights the need for additional education and preparation for nurses caring for patients with SCD and programs to follow up and ensure nurses are using this information to improve the care of these individuals. Two electronic databases were searched, yielding numerous results that were not relevant to the topic of study. Ultimately, nine articles analyzing sickle cell education programs for nurses were included. However, only two articles had information regarding intensive workshops, with one targeting emergency room providers. Critical findings include the shortage of SCD nursing education for all areas of nursing, warranting future development, implementation, and evaluation of educational interventions targeting nurses caring for individuals living with SCD.
- 17 January 2025
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 2 (1)
Open AccessSCD Nursing Education: A Scoping Review
SCD is a rare, inherited blood disorder that disproportionately affects Black patients. Individuals living with SCD experience significant pain crises and complications due to the sickling of red blood cells. These pain crises cause complications that affect every body system and are extremely dangerous, requiring immediate recognition and intervention to prevent severe complications and death. Nurses are the primary care providers for these individuals across the care continuum, but they often lack the knowledge and skills to do so effectively. There is a dearth of nursing education about SCD in undergraduate to post-graduate nursing professional education. This review highlights the need for additional education and preparation for nurses caring for patients with SCD and programs to follow up and ensure nurses are using this information to improve the care of these individuals. Two electronic databases were searched, yielding numerous results that were not relevant to the topic of study. Ultimately, nine articles analyzing sickle cell education programs for nurses were included. However, only two articles had information regarding intensive workshops, with one targeting emergency room providers. Critical findings include the shortage of SCD nursing education for all areas of nursing, warranting future development, implementation, and evaluation of educational interventions targeting nurses caring for individuals living with SCD.